Please click here for publications from previous years
| Author(s) | Title | Year | Citation |
|---|---|---|---|
| Clarke M, Mathew SM, Giles LC, Barr IG, Richmond PC, Marshall HS | The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During Pregnancy | 2024 | Vaccines (Basel) Pubmed link doi: 10.3390/vaccines12121307 |
| Lu C, Barr IG, Lambert S, Mengersen K, Wang L, Yang W, Li Z, Vardoulakis S, Bambrick H, Hu W. | Shifts in seasonal influenza patterns in Australia during and after COVID-19: A comprehensive analysis | 2024 | J Infect Public Health Pubmed link doi: 10.1016/j.jiph.2024.102620 |
| Premachandre CK, Quah PS, Tran BM, Vincan E, Deliyannis G, Wong CY, Diaz-Méndez A, Jackson DC, Reading PC, Browning GF, Vaz PK, Wawegama NK. | Bovine tracheal organoids for studying Mycoplasma bovis respiratory infections. | 2024 | Vet Microbiol. 2024 Dec 10;300:110340 Pubmed link doi: 10.1016/j.vetmic.2024.110340 |
| Hodgson D, Sánchez-Ovando S, Carolan L, Liu Y, Hadiprodjo AJ, Fox A, Sullivan SG, Kucharski AJ. | Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity | 2024 | Vaccine. 2025 Jan 12;44:126579 Pubmed link doi: 10.1016/j.vaccine.2024.126579 |
| Deng YM, Wille M, Dapat C, Xie R, Lay O, Peck H, Daley AJ, Dhanasakeran V, Barr IG. | Influenza A(H5N1) Virus Clade 2.3.2.1a in Traveler Returning to Australia from India, 2024 | 2024 | Emerg Infect Dis. 2025 Jan;31(1):135-138 Pubmed link doi: 10.3201/eid3101.241210 |
| Wille M, Dewar ML, Claes F, Thielen P, Karlsson EA | A call to innovate Antarctic avian influenza surveillance | 2024 | Trends Ecol Evol. 2024 Nov 29:S0169-5347(24)00278-7 Pubmed link doi: 10.1016/j.tree.2024.11.005 |
| Barr IG | Influenza in Australia before, during and after the COVID-19 pandemic | 2024 | Microbiology Australia Oct 45, 188-192 Pubmed link doi:https://doi.org/10.1071/MA24052 |
| Barr IG, Subbarao K | Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses | 2024 | NPJ Vaccines. 2024 Nov 16;9(1):219 Pubmed link doi: 10.1038/s41541-024-01010-y |
| McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall HS, Estcourt MJ, Wadia U, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Cain N, Brizuela R, Faust SN, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond PC | The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-50 and 50-70 years old | 2024 | J Infect. 2024 Nov 14:106346 Pubmed link doi: 10.1016/j.jinf.2024.106346 |
| Waldock J, Cox RJ, Chiu C, Subbarao K, Wildfire A, Barclay W, van Kasteren PB, McCauley J, Russell CA, Smith D, Thwaites RS, Tregoning JS, Engelhardt OG | Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK | 2024 | Influenza Other Respir Viruses. 2024 Nov;18(11):e70014 Pubmed link doi: 10.1111/irv.70014 |
| Wille M, Grillo V, de Gouvea Pedroso SB, Brohier ND, Broz I, Burgoyne C, Crawley A, Davies K, Ford M, Grimsey J, Kung NYH, Luczo JM, Matereke C, Mee PT, Mileto P, Neave MJ, Poon M, Stevens V, Weerasinghe G, Zufan S, Barr IG, Klaassen M, Breed AC, Wong FYK | Incursion of Novel Eurasian Low Pathogenicity Avian Influenza H5 Virus, Australia, 2023 | 2024 | Emerg Infect Dis Pubmed link doi: 10.3201/eid3012.240919 |
| Barr IG | Influenza in Australia before, during and after the COVID-19 pandemic | 2024 | Microbiology Australia Pubmed link https://doi.org/10.1071/MA24052 |
| Wille M, Barr IG | The current situation with H5N1 avian influenza and the risk to humans | 2024 | Intern Med J. 2024 Oct 25 Pubmed link doi: 10.1111/imj.16550 |
| Nazareth J, Martin CA, Pan D, Barr IG, Sullivan SG, Peck H, Veli N, Das M, Bryant L, George N, Gohar M, Gray LJ, Teece L, Vail D, Renals V, Karia A, Renals P, Moss P, Tattersall A, Otter AD, Haldar P, Cooper A, Stephenson I, Wiselka MJ, Tang JW, Nellums L, Pareek M | Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study | 2024 | Lancet Reg Health Eur. 2024 Aug 12;44:101022 Pubmed link doi: 10.1016/j.lanepe.2024.101022 |
| Wille M, Broz I, Cherrington T, Crawley A, Farrugia B, Ford M, Frost M, Grimsey J, Kirkland PD, Latimore S, Lynch SE, Martin S, Matereke C, Mee PT, Neave MJ, O'Dea M, Read AJ, O'Riley K, Stevens V, Thayaparan S, Zufan S, Ban de Gouvea Pedroso S, Grillo V, Breed AC, Barr IG, Holmes EC, Klaassen M, Wong FYK | Contrasting dynamics of two incursions of low-pathogenicity avian influenza virus into Australia. | 2024 | Virus Evol. 2024 Sep 10;10(1):veae076 Pubmed link doi:10.1093/ve/veae076 |
| Yamaji R, Zhang W, Kamata A, Adlhoch C, Swayne DE, Pereyaslov D, Wang D, Neumann G, Pavade G, Barr IG, Peiris M, Webby RJ, Fouchier RAM, Von Dobschütz S, Fabrizio T, Shu Y, Samaan M | Pandemic risk characterisation of zoonotic influenza A viruses using the Tool for Influenza Pandemic Risk Assessment (TIPRA) | 2024 | Lancet Microbe. 2024 Oct 10:100973 Pubmed link doi:10.1016/j.lanmic.2024.100973 |
| Pendrey CGA, Khvorov A, Nghiem S, Rahaman MR, Strachan J, Sullivan SG | Hospitalizations and emergency attendance averted by influenza vaccination in Victoria, Australia, 2017 - 2019 | 2024 | Epidemiol Infect. 2024 Oct 4;152:e111 Pubmed link doi:10.1017/S0950268824001122 |
| Do THT, Wille M, Wheatley AK, Koutsakos M | Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase | 2024 | J Virol. 2024 Oct 3:e0118624 Pubmed link doi:10.1128/jvi.01186-24 |
| McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall H, Estcourt MJ, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Faust SN, Wadia U, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond P | The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-70 years old | 2024 | J Infect. 2024 Sep 26;89(6):106286 Pubmed link doi: 10.1016/j.jinf.2024.106286 |
| Perofsky AC, Huddleston J, Hansen CL, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Lewis N, Whittaker L, Ermetal B, Harvey R, Galiano M, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Sullivan SG, Barr IG, Subbarao K, Krammer F, Bedford T, Viboud C | Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States | 2024 | Elife. 2024 Sep 25;13:RP91849 Pubmed link doi: 10.7554/eLife.91849 |
| Regan AK, Sullivan SG, Arah OA | Maternal influenza vaccination and associated risk of fetal loss: A claims-based prospective cohort study | 2024 | Vaccine. 2024 Sep 10;42(26):126256 Pubmed link doi: 10.1016/j.vaccine.2024.126256 |
| Islam A, Wille M, Rahman MZ, Porter AF, Hosaain ME, Hassan MM, Shirin T, Epstein JH, Klaassen M | Phylodynamics of high pathogenicity avian influenza virus in Bangladesh identifying domestic ducks as the amplifying host reservoir | 2024 | Emerg Microbes Infect. 2024 Dec;13(1):2399268 Pubmed link doi: 10.1080/22221751.2024.2399268 |
| Tessema MB, Feng S, Enosi Tuipulotu D, Farrukee R, Ngo C, Gago da Graça C, Yamomoto M, Utzschneider DT, Brooks AG, Londrigan SL, Man SM, Reading PC | Mouse guanylate-binding proteins of the chromosome 3 cluster do not mediate antiviral activity in vitro or in mouse models of infection. Commun Biol. | 2024 | Commun Biol.2024 Aug 25;7(1):1050 Pubmed link doi: 10.1038/s42003-024-06748-8 |
| McClymont H, Lambert SB, Barr I, Vardoulakis S, Bambrick H, Hu W | Internet-based Surveillance Systems and Infectious Diseases Prediction: An Updated Review of the Last 10 Years and Lessons from the COVID-19 Pandemic | 2024 | J Epidemiol Glob Health. 2024 Aug 14 Pubmed link doi: 10.1007/s44197-024-00272-y |
| Jia X, Crawford JC, Gebregzabher D, Monson EA, Mettelman RC, Wan Y, Ren Y, Chou J, Novak T, McQuilten HA, Clarke M, Bachem A, Foo IJ, Fritzlar S, Carrera Montoya J, Trenerry AM, Nie S, Leeming MG, Nguyen THO, Kedzierski L, Littler DR, Kueh A, Cardamone T, Wong CY, Hensen L, Cabug A, Laguna JG, Agrawal M, Flerlage T, Boyd DF, Van de Velde LA, Habel JR, Loh L, Koay HF, van de Sandt CE, Konstantinov IE, Berzins SP, Flanagan KL, Wakim LM, Herold MJ, Green AM, Smallwood HS, Rossjohn J, Thwaites RS, Chiu C, Scott NE, Mackenzie JM, Bedoui S, Reading PC, Londrigan SL, Helbig KJ, Randolph AG, Thomas PG, Xu J, Wang Z, Chua BY, Kedzierska K | High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases | 2024 | Cell. 2024 Aug 22;187(17):4586-4604.e20 Pubmed link doi: 10.1016/j.cell.2024.07.026 |
| Lu C, Wang L, Barr I, Lambert S, Mengersen K, Yang W, Li Z, Si X, McClymont H, Haque S, Gan T, Vardoulakis S, Bambrick H, Hu W | Developing a Research Network of Early Warning Systems for Infectious Diseases Transmission Between China and Australia | 2024 | China CDC Wkly. 2024 Jul 26;6(30):740-753 Pubmed link doi: 10.46234/ccdcw2024.166 |
| Martín-Sánchez M, Wu P, Adam DC, Yang B, Lim WW, Lin Y, Lau EHY, Sullivan SG, Leung GM, Cowling BJ | An observational study on imported COVID-19 cases in Hong Kong during mandatory on-arrival hotel quarantine | 2024 | Public Health Pract (Oxf). 2024 Jun 21;8:100525 Pubmed link doi: 10.1016/j.puhip.2024.100525 |
| Lim WW, Feng S, Wong SS, Sullivan SG, Cowling BJ | Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections | 2024 | J Infect Dis. 2024 Jul 25;230(1):152-160 Pubmed link doi: 10.1093/infdis/jiae122 |
| Lee K, Williams KV, Englund JA, Sullivan SG | The Potential Benefits of Delaying Seasonal Influenza Vaccine Selections for the Northern Hemisphere: A Retrospective Modeling Study in the United States | 2024 | J Infect Dis. 2024 Jul 25;230(1):131-140 Pubmed link doi: 10.1093/infdis/jiad541 |
| Griffin DWJ, Dymock M, Wong G, Morrissey CO, Lewin SR, Cheng AC, Howard K, Marsh JA, Subbarao K, Hagenauer M, Roney J, Cunningham A, Snelling T, McMahon JH | Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial | 2024 | Trials. 2024 Jul 17;25(1):485 Pubmed link doi: 10.1186/s13063-024-08315-2 |
| Tsang TK, Sullivan SG, Huang X, Wang C, Wang Y, Nealon J, Yang B, Ainslie KEC, Cowling BJ | Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis | 2024 | Am J Epidemiol. 2024 Jun 20:kwae142 Pubmed link doi:10.1093/aje/kwae142 |
| Edler P, Schwab LSU, Aban M, Wille M, Spirason N, Deng YM, Carlock MA, Ross TM, Juno JA, Rockman S, Wheatley AK, Kent SJ, Barr IG, Price DJ, Koutsakos M | Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin | 2024 | Nat Microbiol. 2024 Jun 18 Pubmed link doi: 10.1038/s41564-024-01732-8 |
| Houghton MJ, Balland E, Gartner MJ, Thomas BJ, Subbarao K, Williamson G | The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cells | 2024 | Biofactors. 2024 Jun 17 Pubmed link doi: 10.1002/biof.2084 |
| Farrukee R, Schwab LSU, Barnes JB, Brooks AG, Londrigan SL, Hartmann G, Zillinger T, Reading PC | Induction and antiviral activity of ferret myxovirus resistance (Mx) protein 1 against influenza A viruses | 2024 | Sci Rep. 2024 Jun 12;14(1):13524 Pubmed link doi:0.1038/s41598-024-63314-2 |
| Zhong S, Ng TWY, Skowronski DM, Iuliano AD, Leung NHL, Perera RAPM, Ho F, Fang VJ, Tam YH, Ip DKM, Havers FG, Fry AM, Aziz-Baumgartner E, Barr IG, Peiris M, Thompson MG, Cowling BJ | Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine Status | 2024 | J Infect Dis. 2024 May 15;229(5):1451-1459 Pubmed link doi: 10.1093/infdis/jiad497 |
| Shah SAW, Palomar DP, Barr I, Poon LLM, Quadeer AA, McKay MR | Seasonal antigenic prediction of influenza A H3N2 using machine learning | 2024 | Nat Commun. 2024 May 7;15(1):3833 PubMed link doi:10.1038/s41467-024-47862-9 |
| Adair A, Tan LL, Feng J, Girkin J, Bryant N, Wang M, Mordant F, Chan LJ, Bartlett NW, Subbarao K, Pymm P, Tham WH | Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection | 2024 | Infection.J Virol. 2024 98:e00531-24 Article link https://doi.org/10.1128/jvi.00531-24 |
| Stein AN, Mills CW, McGovern I, McDermott KW, Dean A, Bogdanov AN, Sullivan SG, Haag MDM | Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States | 2024 | Open Forum Infect Dis. 2024 May 2;11(5):ofae175 PubMed link doi:10.1093/ofid/ofae175 |
| Verzele NAJ, Chua BY, Short KR, Moe AAK, Edwards IN, Bielefeldt-Ohmann H, Hulme KD, Noye EC, Tong MZW, Reading PC, Trewella MW, Mazzone SB, McGovern AE | Evidence for vagal sensory neural involvement in influenza pathogenesis and disease | 2024 | PLoS Pathog. 2024 Apr 16;20(4):e1011635 PubMed link doi: 10.1371/journal.ppat.1011635 |
| Stein AN, Pendrey CGA, Muscatello DJ, Van Buynder PG, Fielding JE, Menche JC, Sullivan SG | Estimates of Seasonal Influenza Burden That Could Be Averted by Improved Influenza Vaccines in the Australian Population Aged Under 65 Years, 2015-2019 | 2024 | Influenza Other Respir Viruses. 2024 Apr;18(4):e13289 PubMed link doi:10.1111/irv.13289 |
| Siegers JY, Wille M, Yann S, Tok S, Sin S, Chea S, Porco A, Sours S, Chim V, Chea S, Chhel K, Tum S, Sorn S, Hak M, Thielen P, Dhanasekaran V, Karlsson EA | Detection and phylogenetic analysis of contemporary H14N2 Avian influenza A virus in domestic ducks in Southeast Asia (Cambodia) | 2024 | Emerg Microbes Infect. 2024 Dec;13(1):2297552 PubMed link doi:10.1080/22221751.2023.2297552 |
| Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, McDonald E, Nicholson S, Perrett KP, Pittet LF, Rudraraju R, Stevens NE, Subbarao K, Curtis N; BRACE trial | Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial | 2024 | EBioMedicine. 2024 Apr 23;103:105100 PubMed link doi: 10.1016/j.ebiom.2024.105100 |
| Edwards K, Corocher T, Hersusianto Y, Campbell D, Subbarao K, Neil JA, Monagle P, Ho P | Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I | 2024 | J Virol Methods. 2024 Apr 20;327:114944 PubMed link doi: 10.1016/j.jviromet.2024.114944 |
| Wille M, Atkinson R, Barr IG, Burgoyne C, Bond AL, Boyle D, Christie M, Dewar M, Douglas T, Fitzwater T, Hassell C, Jessop R, Klaassen H, Lavers JL, Leung KK, Ringma J, Sutherland DR, Klaassen M | Long-Distance Avian Migrants Fail to Bring 2.3.4.4b HPAI H5N1 Into Australia for a Second Year in a Row | 2024 | Influenza Other Respir Viruses. 2024 Apr;18(4):e13281 PubMed link doi: 10.1111/irv.13281 |
| Moso MA, Taiaroa G, Steinig E, Zhanduisenov M, Butel-Simoes G, Savic I, Taouk ML, Chea S, Moselen J, O'Keefe J, Prestedge J, Pollock GL, Khan M, Soloczynskyj K, Fernando J, Martin GE, Caly L, Barr IG, Tran T, Druce J, Lim CK, Williamson DA | Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study | 2024 | Lancet Microbe. 2024 Apr;5(4):e317-e325 PubMed link doi: 10.1016/S2666-5247(23)00375-0 |
| Murphy C, Kwan MYW, Chan ELY, Wong JSC, Sullivan SG, Peiris M, Cowling BJ, Lee SL | Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023 | 2024 | Vaccine. 2024 Mar 19;42(8):1878-1882 PubMed link doi: 10.1016/j.vaccine.2024.02.056 |
| Vanslambrouck JM, Neil JA, Rudraraju R, Mah S, Tan KS, Groenewegen E, Forbes TA, Karavendzas K, Elliott DA, Porrello ER, Subbarao K, Little MH | Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection | 2024 | J Virol. 2024 Mar 19;98(3):e0180223 PubMed link doi: 10.1128/jvi.01802-23 |
| Lim WW, Shuo F, Wong SS, Sullivan SG, Cowling BJ | Hemagglutination inhibition antibody titers mediate influenza vaccine efficacy against symptomatic influenza A(H1N1), A(H3N2), and B/Victoria infections | 2024 | J Infect Dis. 2024 Mar 7:jiae122 PubMed link doi: 10.1093/infdis/jiae122 |
| Fan S, Kong H, Babujee L, Presler R Jr, Jester P, Burke D, Pattinson D, Barr I, Smith D, Neumann G, Kawaoka Y | Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera | 2024 | EBioMedicine. 2024 Mar;01:105013 PubMed link doi:10.1016/j.ebiom.2024.105013 |
| Haque S, Mengersen K, Barr I, Wang L, Yang W, Vardoulakis S, Bambrick H, Hu W | Towards development of functional climate-driven early warning systems for climate-sensitive infectious diseases: Statistical models and recommendations | 2024 | Environ Res. 2024 Feb 28;249:118568 PubMed link doi: 10.1016/j.envres.2024.118568 |
| Eales O, Plank MJ, Cowling BJ, Howden BP, Kucharski AJ, Sullivan SG, Vandemaele K, Viboud C, Riley S, McCaw JM, Shearer FM | Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic | 2024 | Emerg Infect Dis. 2024 Feb;30(2):e230768 PubMed link doi: 10.3201/eid3002.230768 |
| Chen J, Neil JA, Tan JP, Rudraraju R, Mohenska M, Sun YBY, Walters E, Bediaga NG, Sun G, Zhou Y, Li Y, Drew D, Pymm P, Tham WH, Rossello FJ, Nie G, Liu X, Subbarao K, Polo JM | Author Correction: A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts | 2024 | Nat Cell Biol. 2024 Jan;26(2):305 PubMed link doi:10.1038/s41556-023-01335-1 |
| Canevari JT,Cheng AC, Wu L, Rowe SL, Wollersheim DE, West D, Majumdar SS,Sullivan, S. G. | The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study. Vaccine. | 2024 | Vaccine. 2024 Jan;42(1):53-58 Pudmed link doi:10.1016/j.vaccine.2023.11.047 |